6ix — Find Your Next Investment

Discover investor relations events, company profiles, and investment opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
17m ago	Amesite Announces Up To $6 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules
18m ago	Creator Platform Beats Global Field Two Years Running, as Social Content Evolves into Social Commerce
18m ago	American Rebel Holdings (NASDAQ: AREB) Announces Nasdaq Trading Resumption and Provides Shareholder Update
19m ago	Personalization at Scale: 3,000 Custom Baseballs, One Unforgettable Adobe Summit
19m ago	First Commerce Bancorp, Inc. Reports First Quarter 2026 Results and Declares a Cash Dividend

About

Beam Therapeutics Inc (NASDAQ:BEAM) — investor relations, events, news, and company updates on 6ix.

Latest News

Beam Therapeutics Announces Publication of BEACON Phase 1/2 Data for risto-cel in Patients with Sickle Cell Disease (SCD) in The New England Journal of Medicine

Beam Therapeutics Announces Compelling Updated Clinical Data from the Ongoing Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) to Support Advancement to Pivotal Development

Beam Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Announces New Liver-Targeted Genetic Disease Program in Phenylketonuria (PKU)

Beam Therapeutics Announces $500 Million Strategic Financing Facility with Sixth Street

Beam Therapeutics to Host Investor Webcast for Fourth Quarter and Year-End 2025 Financial Results and New Liver-targeted Genetic Disease Program

Financials

Revenue

$139.74 M

Market Cap

$2.47 B

EPS

-0.81

Community Chat

Ask AI